Literature DB >> 21056858

Biologics in foot and ankle surgery.

Bryan J Hawkins1.   

Abstract

This article is another review of clinical application of the use of bone morphogenetic proteins, specifically rhBMP2 Infuse Bonegraft, in the treatment of both acute and chronic fracture and fusion situations. Overall experience is reported with particular detail to the use of biologics in the treatment of problems involving the tibia, foot, and ankle.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21056858     DOI： 10.1016/j.fcl.2010.07.003

Source DB:  PubMed          Journal:  Foot Ankle Clin        ISSN： 1083-7515            Impact factor:   1.653


  3 in total

1.  Bone morphogenetic protein and orthopaedic surgery: can we legitimate its off-label use?

Authors:  Aurélien Courvoisier; Frederic Sailhan; Olivier Laffenêtre; Laurent Obert
Journal:  Int Orthop       Date:  2014-09-30       Impact factor: 3.075

2.  Long-term outcome following additional rhBMP-7 application in revision surgery of aseptic humeral, femoral, and tibial shaft nonunion.

Authors:  Simon Hackl; Christian Hierholzer; Jan Friederichs; Alexander Woltmann; Volker Bühren; Christian von Rüden
Journal:  BMC Musculoskelet Disord       Date:  2017-08-07       Impact factor: 2.362

3.  The use of recombinant human bone morphogenetic protein-2 for the treatment of a delayed union following femoral neck open-wedge osteotomy.

Authors:  Axel W A Baltzer; Martin S Ostapczuk; Daniel Stosch; Markus Granrath
Journal:  Orthop Rev (Pavia)       Date:  2012-03-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.